The new report by Expert Market Research titled, ‘Global Non-Invasive Prenatal Testing Market Report and Forecast 2023-2032’, gives an in-depth analysis of the global non-invasive prenatal testing market, assessing the market based on its segments like product and services, method, application, and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.
Get a Free Sample Report with Table of Contents: https://www.expertmarketresearch.com/reports/non-invasive-prenatal-testing-nipt-market/requestsample
The key highlights of the report include:
Market Overview (2018-2032)
- Historical Market Size (2021): 1.74 billion
- Forecast CAGR (2022-2027): 14.30%
- Forecast Market Size (2027): USD 3.88 billion
North America controls a sizable portion of the non-invasive prenatal testing market. This is due to the well-developed healthcare infrastructure as well as the rising maternal mortality rate. The market is growing due to the rising incidence of chromosomal abnormalities and increased awareness of the benefits of non-invasive prenatal testing (NIPT). With major firms increasingly focusing on expanding their non-invasive prenatal testing (NIPT) products, demand is increasing rapidly, fueling market expansion.
As more large insurance companies include NIPT in their coverage plans, market growth is expected to accelerate. Furthermore, the launch of new and technologically improved tests is helping to drive the industry in this region forward. Meanwhile, due to the increasing healthcare infrastructure in rising countries like as China and India, the Asia Pacific area is predicted to rise rapidly. The industry is expected to rise in response to rising public healthcare spending and increased awareness of non-invasive prenatal testing (NIPT). Furthermore, in the projected future, technical advances and innovations in non-invasive prenatal testing (NIPT) are expected to drive market expansion.
Industry Definition and Major Segments
Non-invasive prenatal testing (NIPT), sometimes known as non-invasive prenatal screening (NIPS), is a technique for determining the risk of genetic disorders in the foetus. It’s a safe and effective way to check for Down syndrome, Edwards syndrome, Patau syndrome, and Turner syndrome, among other diseases. This is usually done by analysing tiny DNA fragments that circulate in the blood of pregnant women by 10 weeks of pregnancy.
Read Full Report with Table of Contents: https://www.expertmarketresearch.com/reports/non-invasive-prenatal-testing-nipt-market
The methods available for NIPT are:
- Ultrasound Detection
- Biochemical Screening Tests
- Cell-Free DNA in Maternal Plasma Tests
Based on services and products, the market is divided into:
- Products
- Services
- Consumables
- Instruments
The market is broadly categorized based on its applications into:
- Trisomy
- Microdeletion Syndrome
- Others
Based on the end user, market is categorized into:
- Diagnostic Laboratories
- Hospitals
The regional markets of NIPT are:
- North America
- Europe
- The Asia Pacific
- Latin America
- The Middle East
- Africa
Market Trends
The significant risk of chromosomal abnormalities and the advancing maternal age are driving the non-invasive prenatal testing market forward. The demand for non-invasive prenatal testing (NIPT) is increasing as the chance of genetic disorders increases in pregnancy after 35 years. Obstetricians are increasingly proposing non-invasive diagnostics to their patients in order to ensure a healthy delivery, which is fueling the industry’s growth. Furthermore, the market is expected to grow due to increased research activity for the development of sophisticated technologies for NIPT. The cost-effectiveness of non-invasive prenatal testing (NIPT) is growing as a result of technical improvements, which is expected to boost market growth in the future years.
The industry is predicted to rise due to rising government funding on non-invasive prenatal testing (NIPT) research and development (R&D). Patients can get advanced non-invasive prenatal testing (NIFT) from a variety of laboratories and companies, which is fueling the non-invasive prenatal testing industry’s expansion. Furthermore, rising prevalence of genetic disorders, rising public healthcare spending, and rising awareness are expected to drive market growth throughout the forecast period.
Key Market Players
The major players in the market are Illumina, Inc., Thermo Fisher Scientific Corporation, PerkinElmer, Inc., Agilent Technologies, Inc., F. Hoffmann-La Roche AG and Others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
About Us:
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analyses provide the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today’s competitive market.
Don’t miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organization’s future success by acquiring one of our Expert Market Research reports today.
Media Contact:
Company Name: Claight Corporation
Contact Person: Joe Goldberg, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
